Half-year report on Innate Pharma's liquidity contract with Natixis Securities

Under the liquidity contract entrusted by INNATE PHARMA to NATIXIS SECURITIES, the following assets appeared on the liquidity account as at December 31, 2011:

  • 155,175 shares of INNATE PHARMA, and
  • 34,986.66 euros in cash.

PR in English 37.39 KB
CP en français 33.12 KB